<DOC>
	<DOCNO>NCT01043458</DOCNO>
	<brief_summary>A study investigate process ABT-126 absorbed , distribute , metabolize eliminate body stable schizophrenic volunteer receive treatment atypical antipsychotic .</brief_summary>
	<brief_title>Pharmacokinetic Study ABT-126 Stable Subjects With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Subject sign informed consent ; Current diagnosis schizophrenia ; Clinically stable single secondgeneration ( atypical ) antipsychotic past 8 week ; Meets studyspecific criterion Positive Negative Syndrome Scale ( PANSS ) ; Females pregnant , breastfeed ; Females postmenopausal surgically sterile practice birth control ; Males surgically sterile agree sexually inactive use barrier method birth control Diagnosis schizoaffective disorder ; Diagnosis mental retardation ; Subject substance dependence disorder sustain remission least 1 year ; Acute psychosis hospitalization within past 6 month ; Bipolar disorder , manic episode , dementia , obsessivecompulsive disorder , druginduced psychosis current major depressive disorder ; Current clozapine treatment ; Suicidal ideation behavior ; BMI 39 great ; Relevant drug sensitivity allergy ; Positive hepatitis HIV test result ; positive urine screen drug abuse alcohol ; Recent clinically significant illness/infection surgery ; Recent blood product transfusion , donation loss 5 mL/kg blood ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Pharmacokinetics</keyword>
</DOC>